Welcome to our dedicated page for John Wiley & Sons news (Ticker: WLY), a resource for investors and traders seeking the latest updates and insights on John Wiley & Sons stock.
John Wiley & Sons, Inc. reports developments across its research publishing, research intelligence, and learning businesses. Company news commonly covers quarterly results, Research and Learning performance, AI and data services initiatives, scientific and medical content licensing, open access and journal portfolio expansion, and technology partnerships supporting customer platforms.
Wiley updates also include book publishing announcements, quarterly dividends, share repurchase activity, and leadership changes tied to its Research organization. Its disclosures frequently reference authoritative content, peer-reviewed journals, courseware, assessments, and platforms serving researchers, students, instructors, professionals, institutions, corporations, and R&D teams.
Wiley (WLY) reported fiscal 2027 Q1 results for the quarter ended July 31, 2026, with revenue of $386 million, down 3% year over year, and reaffirmed its full-year outlook.
GAAP operating income was $3 million versus $31 million, with diluted EPS at $(0.23) versus $0.22, mainly due to $11 million of acquisition and integration costs and $17 million of restructuring charges. On a non-GAAP basis at constant currency, adjusted operating income was $31 million (-9%), adjusted EBITDA $68 million (-4%), and adjusted EPS $0.44 (-10%).
Research revenue grew 4% to $293 million, with Research Publishing up 12% including a $13 million, two-month contribution from the Emerald acquisition; Research adjusted EBITDA rose 9% and margin increased 130 bps to 29.6%. Learning revenue declined 19% to $93 million, and Learning adjusted EBITDA fell 56% to $14 million. Corporate expenses on an adjusted EBITDA basis improved 19% ($8 million).
Wiley closed the Emerald Publishing acquisition for about $450 million in cash, targeting $30 million of cost synergies and projecting Emerald to add $78 million of fiscal 2027 revenue, be accretive to adjusted EPS by about $0.10, and dilute free cash flow by $15 million. Net debt rose to $1,185 million, lifting net debt-to-EBITDA to 2.7x, while free cash flow was a use of $70 million versus $100 million a year earlier. The company raised its dividend for the 33rd consecutive year, returning $33 million via dividends and buybacks, and maintained fiscal 2027 guidance for adjusted EPS of $4.60 to $5.05, adjusted EBITDA margin of 26.5%–27.5%, and free cash flow of $205 million.
Wiley (NYSE: WLY) will release its first quarter fiscal 2027 results before market open on Thursday, September 3, 2026. The company will host a conference call at 10:00 a.m. ET the same day to discuss the results, with access via webcast on its investor relations site or by North American and international dial-in numbers.
Wiley (NYSE: WLY) launched its first spectral analysis API portfolio, giving laboratories, instrument vendors, and software platforms direct API access to its spectral databases, analytical algorithms, and predictive models within their own workflows. The portfolio debuts with four core APIs for search, validation, classification, and spectra prediction.
Wiley (NYSE: WLY) has joined the U.S. Department of Energy’s Genesis Mission Consortium, a public‑private partnership building the American Science and Security Platform, an AI‑driven infrastructure to accelerate scientific discovery. Wiley is the only scientific publisher in the consortium, alongside technology companies such as Nvidia, AWS, Microsoft, IBM, and AMD.
According to Wiley, it plans to make its AI‑driven research intelligence tools available to researchers at all DOE national laboratories, contribute expert‑validated workflows and evidence‑linked scientific content, and participate in working groups on AI model validation, scientific data management, and the consortium’s foundational knowledge layer.
Wiley (NYSE: WLY) declared a quarterly cash dividend of $0.3575 per share on Class A and B stock, payable July 23, 2026 to shareholders of record on July 7, 2026. The annual dividend rises to $1.43, its 33rd consecutive yearly increase.
For Fiscal 2026, Wiley reported mid-single digit Research revenue growth, 100 bps Adjusted EBITDA margin expansion, acquisition of Emerald Publishing, $49 million AI revenue (+23% YoY), record 17.7% Adjusted Operating Margin (+260 bps), $195 million Free Cash Flow (+55%), and $174 million returned to shareholders.
Wiley (NYSE: WLY) reported fiscal 2026 revenue of $1,677 million, flat year over year, with GAAP operating income up 25% to $277 million and GAAP EPS rising to $4.16 from $1.53.
Adjusted EBITDA grew 10% to $440 million with margin expanding to 26.2%, while Adjusted EPS increased 15% to $4.19. Research revenue rose 5% and AI revenue reached $49 million, up 23%. Free Cash Flow grew 55% to $195 million and net debt fell to $608 million (1.4x Net Debt-to-EBITDA). Wiley acquired Emerald Publishing to expand Research and projects fiscal 2027 Adjusted EPS of $4.60 to $5.05 and Free Cash Flow of $205 million.
IQVIA (NYSE:IQV) and Wiley released a cross-sector report, “Scientific Discovery & AI: The Science-to-Patient Journey.” The report distills insights from a May 2026 summit with 25+ senior leaders across pharma, academia, health systems, technology and publishing.
It highlights AI’s role across four stages of the healthcare value chain and five high-potential directions, while also noting incentive misalignments that can slow patient impact.
Wiley (NYSE:WLY) will release its fourth quarter and fiscal 2026 earnings before market open on Tuesday, June 16, 2026. Management will host a conference call at 10:00 a.m. ET to discuss the results, with access via webcast and dedicated phone lines.
Wiley (NYSE: WLY) agreed to acquire Emerald Publishing for £337 million (USD 452 million) in an all-cash deal valued at ~7x Adjusted EBITDA including cost synergies. The acquisition expands Wiley’s journal portfolio to ~2,500 titles, strengthens leadership in social sciences, and deepens proprietary content for AI.
Emerald is expected to generate over USD 85 million revenue in 2026 with mid-single-digit growth, 92% recurring subscription revenue, and 85% generated outside North America. Wiley targets ~USD 30 million annual run-rate cost synergies by year three, and expects the deal to be accretive to Adjusted EPS in year one.
Wiley (NYSE:WLY) released the Wiley Registry of Mass Spectral Data 2026, expanding coverage to over 915,500 reference spectra. The new edition adds more than 42,000 GC-MS spectra representing 34,100 compounds, supporting AI-assisted and traditional laboratory workflows across pharmaceuticals, forensics, environment, and materials science.